The Bombay High Court has directed the Patanjali Ayurved company to deposit Rs 50 lakh due to an alleged breach of the court's interim order.

The Court, hearing a plea by the Indian Medical Association (IMA) accusing Patanjali of false claims and attacks on allopathic medicine, stressed the shared responsibility of advertisers and brand ambassadors.

In a recent development, the Supreme Court has chastised the Uttarakhand State Licensing Authority for its inaction regarding misleading advertisements by Patanjali Ayurved Limited.

AstraZeneca, a prominent player in the global COVID-19 vaccine landscape, has made a significant legal acknowledgment regarding its vaccine's potential side effects.

In a recent development, the Supreme Court has taken significant steps to address the issue of misleading advertisements, particularly focusing on protecting the interests of consumers.

Ramdev and Balakrishna submitted an unconditional apology before the Supreme Court on April 9, acknowledging the gravity of their actions. However, the Supreme Court was left unimpressed.

"We will rip you apart," a bench of Justices Hima Kohli and Ahsanuddin Amanullah told the counsel representing the authority in an unusually stern reprimand. 

Ramdev and Balkrishna have been given the final call to file their affidavits in one week.

Patanjali Ayurved Limited's managing director, Acharya Balkrishna, has issued an unconditional apology for his company's misleading claims regarding the miraculous properties of its formulations.

The Supreme Court has taken a stern stance against Patanjali Ayurveda and its managing director, Acharya Balkrishna, issuing a contempt notice for flouting its previous order regarding misleading advertisements.